Monday, June 25, 2012

TEVA - Adjustment

The following adjustment was made today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.

CriteriaValue
Dividend Champions StatusContender
Years of Consecutive Dividend Increases13
Fair Value Estimate$58.00
Target Buy Price$40.60
Target Margin of Safety30.00%
Actual Buy Price$40.00
Actual Margin of Safety31.03%

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
6/25/2012TEVAContinued TradeSTO 1 Jul12 42.50 Call @ 0.19  $19.27

Current Position Summary

Cost Basis($4,000.00)
Income Generated$70.24
Percent Income Generated1.76%
Annualized Income Generated5.34%
Net Profit If Assigned$320.24
Percent Return If Assigned8.01%
Annualized Return If Assigned24.35%
Days Held to Expiration120 days

Trade History

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
3/22/2012TEVACSP Margin UsedCSP 100 TEVA @ 40.00 ($4,000.00) 
3/22/2012TEVAInitial Put OptionSTO 1 May12 40.00 Put @ 0.51Exercised $50.97
5/18/2012TEVACSP Margin ReturnedCSP 100 TEVA @ -40.00 $4,000.00 
5/18/2012TEVAStock AssignedEX 1 May12 40.00 Put @ -40.00 ($4,000.00) 
6/25/2012TEVAContinued TradeSTO 1 Jul12 42.50 Call @ 0.19  $19.27
7/20/2012TEVA Totals ($4,000.00)$70.24
DTE120 Percent Income/Annualized 1.76%5.34%